N. Goulden

J. Cornish, K. Vettenranta, N. Goulden, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion

P. Kearns, J. Hancock, C. Harrison, 2020, British journal of haematology.

Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all‐trans retinoic acid

R. Jamal, P. Veys, D. Grimwade, 1998, British journal of haematology.

‘Stroke-like syndrome’ caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial

J. Bond, R. Hough, J. Moppett, 2013, Leukemia.

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation

J. Cornish, N. Goulden, D. Marks, 2001, British journal of haematology.

Outcome for children and young people with Early T‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003

R. Wade, R. Hough, A. Vora, 2014, British journal of haematology.

G. Hale, H. Waldmann, J. Cornish, 1996, British journal of haematology.

Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience

P. Veys, R. Hough, S. Samarasinghe, 2012, British journal of haematology.

Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial

D. Linch, J. Hancock, S. Samarasinghe, 2018, Haematologica.

Treosulfan‐containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non‐malignant disease and significant co‐morbidities

P. Veys, P. Amrolia, B. Greystoke, 2008, British journal of haematology.

Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation

J. Cornish, N. Goulden, D. Marks, 2005, Bone Marrow Transplantation.

Bone marrow transplantation from volunteer unrelated donors.

N. Goulden, J. Cornish, A. Oakhill, 1995, Cancer treatment reviews.

Haploidentical stem cell transplantation for children with acute leukaemia

J. Cornish, N. Goulden, D. Marks, 2006, British journal of haematology.

Disseminated cutaneous granulomatous eruptions associated with myelodysplastic syndrome and acute myeloid leukaemia

J. Hunter, N. Goulden, J. Vestey, 1993, Clinical and experimental dermatology.

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation

N. Goulden, J. Cornish, A. Oakhill, 2000, Bone Marrow Transplantation.

Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients

P. Veys, P. Amrolia, R. Chiesa, 2013, Bone Marrow Transplantation.

A double cure: Omenn syndrome and β thalassaemia successfully treated with mismatched unrelated donor transplantation

P. Veys, N. Goulden, W. Qasim, 2012, Bone Marrow Transplantation.

Kingdom experience transplantation in children with primary immunodeficiency: United Treosulfan-based conditioning regimens for hematopoietic stem cell

P. Veys, P. Amrolia, W. Qasim, 2012 .

Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience.

A. Gennery, P. Veys, P. Amrolia, 2011, Blood.

The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis

P. Veys, P. Amrolia, N. Goulden, 2008, Bone Marrow Transplantation.

Pre‐emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein–Barr virus‐associated lymphoproliferative disease following stem cell transplantation

P. Veys, A. Worth, P. Amrolia, 2011, British journal of haematology.

Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.

S. Richards, A. Vora, N. Goulden, 2011, Blood.

Comparison of Lentiviral and Sleeping Beauty Mediated αβ T Cell Receptor Gene Transfer

A. Field, C. Vink, A. Thrasher, 2013, PloS one.

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

A. Baruchel, L. Silverman, J. Whitlock, 2016, Haematologica.

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Great, T. Révész, S. Love, 2010, The Lancet.

Dismal long‐term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?

J. Moppett, J. Cornish, N. Goulden, 2009, British journal of haematology.

Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia

J. Soulier, E. Clappier, C. Mecucci, 2015, Haematologica.

Eye on the B-ALL: B-cell receptor repertoires reveal persistence of numerous B-lymphoblastic leukemia subclones from diagnosis to relapse

J. Chi, P. Kellam, R. Bashford-Rogers, 2016, Leukemia.

The study of minimal residual disease in acute lymphoblastic leukaemia

M. Potter, N. Goulden, K. Langlands, 1995, Clinical molecular pathology.

Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy.

C. Pui, R. Pieters, L. Silverman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

J. Hancock, M. Potter, N. Goulden, 1998, British journal of haematology.

Targeting acute myeloid leukemia by drug-induced c-MYB degradation

M. Hubank, C. Zwaan, A. Khwaja, 2018, Leukemia.

The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia.

M. Potter, N. Goulden, A. Oakhill, 1993, European journal of cancer.

PCR of Gene Rearrangements for the Detection of Minimal Residual Disease in Childhood ALL.

M. Potter, N. Goulden, K. Langlands, 1996, Methods in molecular medicine.

Aberrant transcriptional pathways in t(12;21) Acute Lymphoblastic Leukemia

M. Hubank, J. Bartram, T. Brooks, 2016 .

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

R. Wade, S. Richards, J. Hancock, 2013, The Lancet. Oncology.

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.

R. Wade, J. Hancock, R. Hough, 2014, The Lancet. Oncology.

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting;

Jeremy Hancock, Margaret Helliwell, Sarah Lawson, 2009, Haematologica.

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial

Vaskar Saha, Tamas Revesz, Anthony V. Moorman, 2014, PloS one.

First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL

K. Peggs, P. Veys, S. Samarasinghe, 2015 .

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia

R. Wade, A. Enshaei, D. O’Connor, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997–2003

R. Wade, J. Bartram, J. Hancock, 2016, Archives of Disease in Childhood.

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

J. Hancock, J. Cornish, N. Goulden, 1998, Blood.

R. Wade, D. O’Connor, R. Hough, 2014, Blood.

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

J. Hancock, J. Cornish, N. Goulden, 1998 .

Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trial.

P. Kearns, G. Hempel, R. Hough, 2019, European journal of cancer.

Alemtuzumab (Campath IH) in Conditioning Therapy with Cyclophosphamide and Total Body Irradiation in Matched and Mismatched Unrelated Donor Transplantation of Children with Acute Lymphoblastic Leukaemia: A Report from 3 U.K. Centres.

P. Veys, J. Cornish, N. Goulden, 2004 .

The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation

N. Goulden, D. Marks, A. Oakhill, 2002, British Journal of Haematology.

M. Potter, P. Humphries, N. Goulden, 2011 .

Haploidentical related transplants and unrelated donor transplants with T cell addback.

P. Veys, N. Goulden, G. Davies, 1998, Bone marrow transplantation.

Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR

J. Hancock, N. Goulden, A. Oakhill, 2003, Leukemia.

Third‐party virus‐specific T cells eradicate adenoviraemia but trigger bystander graft‐versus‐host disease

P. Veys, P. Amrolia, R. Chiesa, 2011, British journal of haematology.

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma

P. Veys, P. Amrolia, N. Goulden, 2011 .

Oesophageal Candidiasis in an HIV-Negative Individual Treated with Factor VIII Concentrate

H. Watson, N. Goulden, C. Ludlam, 1992, Thrombosis and Haemostasis.

One in 10 million: a case of cleidocranial dysplasia and acute lymphoblastic leukaemia--more than just a coincidence?

A. Gardham, N. Goulden, E. Forsythe, 2012, Clinical dysmorphology.

Accurate Sample Assignment in a Multiplexed, Ultrasensitive, High-Throughput Sequencing Assay for Minimal Residual Disease.

Tony Brooks, Gary Wright, Jack Bartram, 2016, The Journal of molecular diagnostics : JMD.

Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALL.

N. Goulden, C. Steward, 2002, Best practice & research. Clinical haematology.

UKALL 2011: Randomised Trial Investigating a Short Induction Dexamethasone Schedule for Children and Young Adults with Acute Lymphoblastic Leukaemia

P. Kearns, R. Hough, S. Samarasinghe, 2017 .

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

J. Hancock, J. Cornish, M. Potter, 1998, British journal of haematology.

Virus‐associated haemophagocytic syndrome: further evidence for a T‐cell mediated disorder

H. Watson, N. Goulden, L. Manson, 1994, British journal of haematology.

Prospective evaluation of quality of life in children treated in UKALL 2003 for acute lymphoblastic leukaemia: A cohort study

G. Buck, C. Stride, A. Vora, 2017, Pediatric blood & cancer.

Late intracranial hemorrhage in childhood lymphoblastic leukemia.

O. Eden, N. Goulden, 1991, Pediatric hematology and oncology.

The role of plasma exchange for TTP/HUS post-bone marrow transplant.

N. Goulden, J. Cornish, A. Oakhill, 1996, Bone marrow transplantation.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

G. Lucchini, A. Hackshaw, P. Veys, 2019, Nature Medicine.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

G. Lucchini, A. Hackshaw, P. Veys, 2019, Nature Medicine.

Genotype-Speci fi c Minimal Residual Disease Interpretation Improves Strati fi cation in Pediatric Acute Lymphoblastic Leukemia

Samarasinghe, Sujith, R. Wade, 2017 .

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

R. Wade, J. Hancock, R. Hough, 2014 .

High‐throughput sequencing of peripheral blood for minimal residual disease monitoring in childhood precursor B‐cell acute lymphoblastic leukemia: A prospective feasibility study

M. Hubank, J. Bartram, J. Hancock, 2021, Pediatric blood & cancer.

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial

D C Linch, M R Mansour, R E Gale, 2013, Leukemia.

The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia

J. Moppett, N. Goulden, A. Oakhill, 2003, Journal of clinical pathology.

Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

Kiranmoy Das, A. Vora, A. Moorman, 2022, British journal of haematology.

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003

R. Wade, S. Richards, A. Vora, 2008 .

High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments

M. Hubank, J. Bartram, C. Halsey, 2017, Haematologica.

SSBP2-CSF1R Is a Recurrent Fusion in B-Other Acute Lymphoblastic Leukaemia with Variable Clinical Outcome

C. Harrison, C. Schwab, A. Vora, 2014 .

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

R. Pieters, R. Pieters, H. Dombret, 2010, Leukemia.

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

R. Wade, R. Hough, A. Vora, 2013 .

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003

R. Wade, S. Richards, A. Vora, 2008 .

Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial

R. Wade, A. Enshaei, J. Hancock, 2022, Journal of Clinical Oncology.

Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens: Results of the Medical Research Council Trial UKALL2003.

S. Richards, J. Hancock, A. Vora, 2008 .

The role of routine surveillance for silent central nervous system relapse in children with acute lymphoblastic leukaemia

R. Hough, S. Samarasinghe, A. Vora, 2012, British journal of haematology.

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

G. Lucchini, A. Hackshaw, P. Veys, 2019, Blood.

P. Veys, A. Worth, P. Amrolia, 2011, British journal of haematology.

IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome.

R. Wade, A. Enshaei, C. Harrison, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A boy frightened of going to bed and bumps in the night

A. Gupta, S. Padley, N. Goulden, 2009, BMJ : British Medical Journal.

Measurement of Minimal Residual Disease in Children Undergoing Allogeneic Stem Cell Transplant for Acute Lymphoblastic Leukemia

J. Moppett, N. Goulden, A. Oakhill, 2003 .

D. Linch, J. Hancock, S. Samarasinghe, 2018, Haematologica.